OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Yan Zhou, Yang Dong, Qingcheng Yang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 415

Showing 1-25 of 415 citing articles:

Advancing therapy for osteosarcoma
Jonathan Gill, Richard Görlick
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 10, pp. 609-624
Closed Access | Times Cited: 562

CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data
Congxue Hu, Tengyue Li, Yingqi Xu, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D870-D876
Open Access | Times Cited: 559

Macrophage diversity in cancer revisited in the era of single-cell omics
Ruoyu Ma, Annabel Black, Bin‐Zhi Qian
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 546-563
Open Access | Times Cited: 382

Applications of single-cell sequencing in cancer research: progress and perspectives
Yalan Lei, Rong Tang, Jin Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 371

Osteosarcoma
Hannah C. Beird, Stefan Bielack, Adrienne M. Flanagan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 296

Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
David Y. Oh, Lawrence Fong
Immunity (2021) Vol. 54, Iss. 12, pp. 2701-2711
Open Access | Times Cited: 295

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Aiping Zhang, Kai Miao, Heng Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 3019-3033
Open Access | Times Cited: 156

Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma
Yun Liu, Wenyu Feng, Yan Dai, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 120

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis
Kun Xu, Runtian Wang, Hui Xie, et al.
Oncogenesis (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 110

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 107

Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis
Yue Chen, Hua Wang, Qiudong Yang, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1074-1096
Open Access | Times Cited: 104

High-throughput single-сell sequencing in cancer research
Qingzhu Jia, Han Chu, Jin Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 103

The Era of Cytotoxic CD4 T Cells
Mara Cenerenti, Margaux Saillard, Pedro Romero, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102

Spatial omics: Navigating to the golden era of cancer research
Yingcheng Wu, Yifei Cheng, Xiangdong Wang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 94

The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives
Shuo Wang, Si-Tong Sun, Xinyue Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2943-2943
Open Access | Times Cited: 77

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 75

Advances in Osteosarcoma
Isidora Panez-Toro, Javier Muñoz-García, Jorge William Vargas-Franco, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 4, pp. 330-343
Open Access | Times Cited: 72

Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis
Yingying Han, Dan Wang, Lushan Peng, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 71

Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma
Weijian Liu, Hongzhi Hu, Zengwu Shao, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 52

Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 43

Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 35

Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss
Hui Wang, Kimon Divaris, Bohu Pan, et al.
Cell (2024) Vol. 187, Iss. 14, pp. 3690-3711.e19
Open Access | Times Cited: 34

Multiplex protein imaging in tumour biology
Natalie de Souza, Shan Zhao, Bernd Bodenmiller
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 171-191
Closed Access | Times Cited: 33

Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response
Alexander Coulton, Jun Murai, Danwen Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27

Page 1 - Next Page

Scroll to top